Maybe Canadian government can step up for Theralase The U.S. government has awarded $176 million to vaccine maker Moderna for development of an mRNA-based influenza shot.
The funding was awarded through the Biomedical Advanced Research and Development Authority, or BARDA, and will support late-stage testing of a vaccine targeting H5 influenza virus. This type of virus is also known as avian, or bird flu, and includes the H5N1 strain that’s currently spreading among livestock in the U.S.
The agreement, which was made through BARDA’s Rapid Response Partnership Vehicle, also includes options for large-scale production and pandemic response.